[1]WILLIAMS J,KOSTIUK M,BIRON VL.Molecular detection methods in HPV-related cancers [J].Frontiers in Oncology,2022,12:864820.
[2]YUAN Y,CAI X,SHEN F,et al.HPV post-infection microenvironment and cervical cancer [J].Cancer Letters,2021,497:243-254.
[3]INTURRISI F,DE SANJOS S,DESAI KT,et al.A rapid HPV typing assay to support global cervical cancer screening and risk-based management:A cross-sectional study [J].International Journal of Cancer,2023,154:241-250.
[4]YIMER NB,MOHAMMED MA,SOLOMON K,et al.Cervical cancer screening uptake in Sub-Saharan Africa:a systematic review and meta-analysis [J].Public Health,2021,195:105-111.
[5]王全志,丁伟,田少华.浆膜腔脱落细胞学制片方法质量控制的对比研究[J].诊断病理学杂志,2015,22(01):60-62.
WANG QZ,DING W,TIAN SH.Comparative study on quality control of cytological slide preparation for membrane cavity shedding cells[J].Journal of Diagnostic Pathology,2015,22(01):60-62.
[6]SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].A Cancer Journal for Clinicians,2021,71(3):209-249.
[7]RAMREZ AT,VALLS J,BAENA A,et al.Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America:an analysis within the ESTAMPA study [J].Lancet Regional Health Americas,2023,26:100593.
[8]WANG HY,KIM H,PARK S,et al.Analytical performance evaluation of the HPV onco check assay for detection of high-risk HPV infection in liquid-based cervical samples [J].Experimental and Molecular Pathology,2019,106:149-156.
[9]康红,叶延程,樊平.HPV联合TCT检测在宫颈癌筛查中的应用[J].现代肿瘤医学,2020,28(02):283-286.
KANG H,YE YC,FAN P.The application of HPV combined TCT testing in cervical cancer screening[J].Modern Oncology,2020,28(02):283-286.
[10]江琴,吴钊,唐倩,等.宫颈液基细胞学筛查阴性及高危型人乳头瘤病毒筛查阳性患者临床病理特征分析[J].现代肿瘤医学,2022,30(17):3191-3195.
JIANG Q,WU Z,TANG Q,et al.Analysis of clinicopathological characteristics in cervical liquid-based thinlayer cytologic test negative and high risk human papillomavirus screening positive women[J].Modern Oncology,2022,30(17):3191-3195.
[11]KOLIOPOULOS G,NYAGA VN,SANTESSO N,et al.Cytology versus HPV testing for cervical cancer screening in the general population [J].The Cochrane Database of Systematic Reviews,2017,8(8):Cd008587.
[12]SHIDHAM VB.Role of immunocytochemistry in cervical cancer screening [J].CytoJournal,2022,19:42.
[13]RAJARAM S,GUPTA B.Screening for cervical cancer:Choices & dilemmas [J].The Indian Journal of Medical Research,2021,154(2):210-220.
[14]GAVINSKI K,DINARDO D.Cervical cancer screening [J].The Medical Clinics of North America,2023,107(2):259-269.
[15]SHIDHAM VB.CellBlockistry:Chemistry and art of cell-block making-A detailed review of various historical options with recent advances [J].CytoJournal,2019,16:12.
[16]SHIDHAM VB,MEHROTRA R,VARSEGI G,et al.p16 immunocytochemistry on cell blocks as an adjunct to cervical cytology:Potential reflex testing on specially prepared cell blocks from residual liquid-based cytology specimens [J].CytoJournal,2011,8:1.
[17]AL AMRI W,AL SALMI I,AL NABHANI SK,et al.A rare and challenging case of uterine mass successfully reported in a cervical smear [J].CytoJournal,2023,20:35.
[18]SUNG JA,NIKAS IP,KIM H,et al.Diagnostic distribution and pitfalls of glandular abnormalities in cervical cytology:a 25-year single-center study [J].Journal of Pathology and Translational Medicine,2022,56(6):354-360.
[19]XING W,HOU AY,FISCHER A,et al.The cellient automated cell block system is useful in the differential diagnosis of atypical glandular cells in Papanicolaou tests [J].Cancer Cytopathology,2014,122(1):8-14.
[20]SATTURWAR S,PANTANOWITZ L.Architectural aspects of cell-blocks as small biopsies [J].CytoJournal,2021,18:5.
[21]SHIDHAM VB.Cell-blocks and other ancillary studies (including molecular genetic tests and proteomics) [J].CytoJournal,2021,18:4.